What is the recommended dosage of cefixime (Cefixime) for various infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefixime Dosing Recommendations

For adults, cefixime is dosed at 400 mg orally as a single daily dose for most infections, though this can be divided into 200 mg twice daily to reduce gastrointestinal side effects; for pediatric patients 6 months and older, the dose is 8 mg/kg/day given once daily or divided into 4 mg/kg every 12 hours. 1

Adult Dosing

Standard Infections

  • 400 mg orally once daily is the FDA-approved dose for uncomplicated urinary tract infections, otitis media, pharyngitis/tonsillitis, acute exacerbations of chronic bronchitis, and uncomplicated gonorrhea 1
  • The 400 mg dose may be given as a single daily administration or divided into 200 mg twice daily 1, 2
  • Divided dosing (200 mg twice daily) is preferred as it reduces gastrointestinal adverse effects compared to once-daily 400 mg dosing 2, 3

Uncomplicated Gonorrhea

  • Single oral dose of 400 mg for uncomplicated cervical/urethral gonococcal infections 1
  • Important caveat: Cefixime is no longer recommended as first-line therapy for gonorrhea in the United States due to rising resistance 4
  • Cefixime provides lower and less sustained bactericidal levels than ceftriaxone 125 mg IM, with only 97.1-97.4% cure rates for urogenital/anorectal gonorrhea compared to 99.1% for ceftriaxone 4
  • Cefixime has limited efficacy for pharyngeal gonorrhea 4

Streptococcal Infections

  • For pharyngitis/tonsillitis caused by Streptococcus pyogenes, continue treatment for at least 10 days regardless of clinical improvement 1

Pediatric Dosing (≥6 months old)

Standard Dose

  • 8 mg/kg/day of oral suspension 1
  • May be given as a single daily dose or divided into 4 mg/kg every 12 hours 1
  • Children weighing >45 kg or >12 years should receive the adult dose of 400 mg daily 1

Weight-Based Dosing Table

The FDA label provides specific volume recommendations based on weight 1:

  • 5-7.5 kg: 50 mg/day (2.5 mL of 100 mg/5 mL suspension)
  • 7.6-10 kg: 80 mg/day (4 mL of 100 mg/5 mL or 2 mL of 200 mg/5 mL)
  • 10.1-12.5 kg: 100 mg/day (5 mL of 100 mg/5 mL or 2.5 mL of 200 mg/5 mL)
  • 12.6-20.5 kg: 150 mg/day (7.5 mL of 100 mg/5 mL or 4 mL of 200 mg/5 mL)
  • 20.6-28 kg: 200 mg/day (10 mL of 100 mg/5 mL or 5 mL of 200 mg/5 mL)
  • ≥45 kg: 400 mg/day (adult dose)

Critical Otitis Media Consideration

  • Use suspension formulation only for otitis media—do not substitute tablets or capsules 1
  • The suspension achieves higher peak blood levels than tablets at equivalent doses, which is essential for otitis media treatment 1

Renal Impairment Dosing

Dose Adjustments for Adults

  • CrCl ≥60 mL/min: Normal dose (400 mg daily) 1
  • CrCl 21-59 mL/min: 260 mg daily (13 mL of 100 mg/5 mL suspension or 6.5 mL of 200 mg/5 mL suspension) 1
  • CrCl ≤20 mL/min or on dialysis: 172 mg daily (8.6 mL of 100 mg/5 mL suspension or 4.4 mL of 200 mg/5 mL suspension) 1
  • Neither hemodialysis nor peritoneal dialysis removes significant drug amounts 1

Special Clinical Contexts

Enteric Fever (Typhoid)

  • 8 mg/kg/day as a single daily dose for children >28 days old 5
  • 400 mg orally once daily for adults 5
  • Treatment duration: 7-14 days 5
  • Important limitation: Cefixime showed significantly more treatment failures and longer fever duration compared to ofloxacin in randomized trials of typhoid fever 5
  • Azithromycin or ceftriaxone are preferred first-line agents for enteric fever due to better efficacy 5

Urinary Tract Infections

  • 400 mg daily (200 mg twice daily preferred) for uncomplicated UTIs 1, 2
  • For complicated UTIs, sensitivity testing is mandatory before initiating cefixime, as gram-positive and non-fermenting organisms resistant to cefixime may be present 2
  • Cefixime achieves only about 20% urinary excretion as active drug, lower than some other oral cephalosporins 2

Important Clinical Caveats

Resistance Concerns

  • Do not use for gonorrhea as routine first-line therapy—ceftriaxone 250 mg IM is now the only recommended cephalosporin 4
  • Rising minimum inhibitory concentrations (MICs) to cefixime have been documented, particularly in the Western United States and among men who have sex with men 4

Administration Considerations

  • May be administered without regard to food for capsules 1
  • Always specify concentration when prescribing suspension in milliliters, as two concentrations exist (100 mg/5 mL and 200 mg/5 mL) 1

Comparative Efficacy

  • Cefixime provides lower and less sustained bactericidal levels than injectable ceftriaxone at equivalent antimicrobial spectrum 4, 6
  • The 3-hour elimination half-life permits simplified once or twice daily dosing 7

References

Research

[Cefixime, the first oral third-generation cephalosporin].

Presse medicale (Paris, France : 1983), 1989

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Enteric Fever in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Oral Cephalosporin Regimens for Uncomplicated Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.